maxim 100 fs flydende bejdse
syngenta nordics a/s - fludioxonil - flydende bejdse - 100 g/l fludioxonil
tachigaren 70 wp vanddispergerbart pulver
sumi agro europe limited, zweigniederlassung deutschland - hymexazol - vanddispergerbart pulver - 700 g/kg hymexazol
wakil xl vanddispergerbart granulat
syngenta nordics a/s - fludioxonil, cymoxanil, metalaxyl-m - vanddispergerbart granulat - 50 g/kg fludioxonil ; 100 g/kg cymoxanil ; 169 g/kg metalaxyl-m
ally 20 sx vandopløseligt granulat
fmc agricultural solutions a/s (tidligere: cheminova a/s) - metsulfuron-methyl, metsulfuron - vandopløseligt granulat - 200 g/kg metsulfuron-methyl ; (~ 193 g/kg metsulfuron)
harmony 50 sx vandopløseligt granulat
fmc agricultural solutions a/s (tidligere: cheminova a/s) - thifensulfuron-methyl, thifensulfuron - vandopløseligt granulat - 500 g/kg thifensulfuron-methyl ; (~ 482 g/kg thifensulfuron)
harmony plus 50 sx vandopløseligt granulat
fmc agricultural solutions a/s (tidligere: cheminova a/s) - tribenuron-methyl, tribenuron, thifensulfuron-methyl, thifensulfuron - vandopløseligt granulat - 167 g/kg tribenuron-methyl ; (~ 161 g/kg tribenuron) ; 333 g/kg thifensulfuron-methyl ; (~ 321 g/kg thifensulfuron)
vibrance sb flydende bejdse
syngenta nordics a/s - fludioxonil, metalaxyl-m, sedaxane - flydende bejdse - 22,5 g/l fludioxonil ; 14,4 g/l metalaxyl-m ; 15 g/l sedaxane
covid-19 vaccine (inactivated, adjuvanted) valneva
valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vacciner - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.
pandemic influenza vaccine h5n1 astrazeneca (previously pandemic influenza vaccine h5n1 medimmune)
astrazeneca ab - reassortant influenzavirus (levende svækket) af følgende stamme: a / vietnam / 1203/2004 (h5n1) stamme - influenza, human - vacciner - profylakse af influenza i en officielt erklæret pandemisk situation hos børn og unge fra 12 måneder til under 18 år. pandemic influenza vaccine h5n1 astrazeneca bør anvendes i overensstemmelse med officielle retningslinjer.
bimervax
hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - vacciner - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.